WLFC Q1 2026 Earnings Strong EPS Surprise of 3537 Outpaces Expectations Actuate Therapeutics Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss RRR Q1 2026 Earnings EPS Beat Drives Positive Market Response ODFL Q1 2026 Earnings Earnings Beat Estimates Amid Sustained Cost Discipline PBT Q3 2009 Earnings Royalty Income Misses Estimates Yet Stock Gains TRGP Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions